An oral SARS-CoV-2 M
pro
inhibitor clinical candidate for the treatment of COVID-19
Keyword(s):
Keyword(s):
2015 ◽
Vol 25
(22)
◽
pp. 5427-5436
◽
2011 ◽
Vol 2
(11)
◽
pp. 824-827
◽
2018 ◽
Vol 9
(7)
◽
pp. 623-628
◽
2012 ◽
Vol 287
(49)
◽
pp. 41245-41257
◽